Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 2296-5262|23|1|60-62

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.1, 2000-03, pp. : 60-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I Clinical Trial of a Day-1, -3, -5 Every 3 WeeksPhase I Clinical Trial of Day-1, -3, -5 Every 3 Weeks Schedule with Titanocene Dichloride (MKT 5) in Patients with Advanced Cancer. (Phase I Study Group of the AIO of the German Cancer Society)

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2001-01 ,pp. : 576-579

Karger

Access to resources Recommend Favorite

Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 2-8

Karger

Access to resources Recommend Favorite

Final Safety and Efficacy Analysis of a Phase I/II Trial with Imatinib and Vinorelbine for Patients with Metastatic Breast Cancer

By  

Oncology, Vol. 87, Iss. 5, 2014-08 ,pp. : 300-310

Karger

Access to resources Recommend Favorite

Phase II Trial of Pegylated Liposomal Doxorubicin-Cyclophosphamide Combination as First-Line Chemotherapy in Older Metastatic Breast Cancer Patients

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 210-214

Karger

Access to resources Recommend Favorite

A Phase II Trial of Gallium Nitrate in Patients with Androgen-Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 63, Iss. 2, 1999-12 ,pp. : 120-125

Karger

Access to resources Recommend Favorite